Support our online development, and advance our onground research initiatives in free market economics, as we seek to showcase the brightest Next-Gen minds.
THE ME-P DISCLAIMER: Posts, comments and opinions do not necessarily represent iMBA, Inc., but become our property after submission. Copyright © 2006 to-date. iMBA, Inc allows colleges, universities, medical and financial professionals and related clinics, hospitals and non-profit healthcare organizations to distribute our proprietary essays, photos, videos, audios and other documents; etc. However, please review copyright and usage information for each individual asset before submission to us, and/or placement on your publication or web site. Attestation references, citations and/or back-links are required. All other assets are property of the individual copyright holder.
By Dr. David Edward Marciniko MBA CMP™
SPONSOR: http://www.MarcinkoAssociates.com
***
***
DEFINITION: According to the Food and Drug Administration [FDA], the broad scope of digital health includes categories such as mobile health (mHealth), health information technology (IT), wearable devices, tele-health and tele-medicine, and personalized medicine. From mobile medical apps and software that support the clinical decisions doctors make every day to artificial intelligence and machine learning, digital technology has been driving a revolution in health care. Digital health tools have the vast potential to improve our ability to accurately diagnose and treat disease and to enhance the delivery of health care for the individual. Digital health technologies use computing platforms, connectivity, software, and sensors for health care and related uses. These technologies span a wide range of uses, from applications in general wellness to applications as a medical device. They include technologies intended for use as a medical product, in a medical product, as companion diagnostics, or as an adjunct to other medical products (devices, drugs, and biologics). They may also be used to develop or study medical products.
Cite: http://tinyurl.com/2jbafuc7
***
As many investors predicted, digital health funding took a dive in 2023, according to Rock Health’s year-end funding report. Startups got creative to stay afloat but many digital health founders will have to “face the music” in 2024, the VC firm’s analysts say.
CITE: https://www.r2library.com/Resource
Editor’s Note: I am on the Advisory Board of Medblob™a start-up based in Boston, MA. The digital mission of Medblob™ is to improve community and national health by allowing patients to better manage their health, providers to better treat their patients, and researchers to have the best information to discover cures to the most prevalent and pernicious diseases.
COMMENTS APPRECIATED
Thank You
***
***
Share this:
Filed under: "Ask-an-Advisor", "Doctors Only", Career Development, CMP Program, Ethics, Funding Basics, Glossary Terms, Health Economics, Healthcare Finance, iMBA, Inc., Information Technology, Investing, Marcinko Associates, Touring with Marcinko | Tagged: CMP, digital health funding, digital health funding dives, digital start ups, eeHRs, EMRs, FDA, Heather Landi, HIT, Information Technology, IT, JPM, lelemedicine, Marcinko, Marcinko Associates, Medblob™, medical innovators, mHealth, rock health, start ups, start-up, teleHealth, VC, venture capitalists |
The Leading Business Education Network for Doctors, Financial Advisors and Health Industry Consultants 
Leave a comment